Detalles de la búsqueda
1.
Gene Therapy in Patients with Transfusion-Dependent ß-Thalassemia.
N Engl J Med
; 378(16): 1479-1493, 2018 04 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-29669226
2.
Reduced-toxicity conditioning regimen with busulfan, fludarabine, rATG, and 400 cGy TBI in pediatric patients undergoing hematopoietic stem cell transplant for high-risk hematologic malignancies.
Pediatr Blood Cancer
; 68(8): e29087, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34022093
3.
SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery.
Blood
; 132(17): 1737-1749, 2018 10 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-30154114
4.
Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study.
Blood
; 130(25): 2718-2727, 2017 12 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-29021228
5.
Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression.
Biol Blood Marrow Transplant
; 24(10): 2040-2046, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29933069
6.
Late Effects in Pediatric High-risk Neuroblastoma Survivors After Intensive Induction Chemotherapy Followed by Myeloablative Consolidation Chemotherapy and Triple Autologous Stem Cell Transplants.
J Pediatr Hematol Oncol
; 40(1): 31-35, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28538090
7.
High-dose chemotherapy and autologous hematopoietic stem-cell rescue for treatment of relapsed and refractory Wilms tumor: Re-evaluating outcomes.
Pediatr Hematol Oncol
; 35(5-6): 316-321, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30681039
8.
Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less than Three Years of Age.
Biol Blood Marrow Transplant
; 23(8): 1327-1334, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28461213
9.
Early mixed T-cell chimerism is predictive of pediatric AML or MDS relapse after hematopoietic stem cell transplant.
Pediatr Blood Cancer
; 64(9)2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28266766
10.
The Impact of High-resolution HLA-A, HLA-B, HLA-C, and HLA-DRB1 on Transplant-related Outcomes in Single-unit Umbilical Cord Blood Transplantation in Pediatric Patients.
J Pediatr Hematol Oncol
; 39(1): 26-32, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27820121
11.
A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33+ Acute Myeloid Leukemia.
Biol Blood Marrow Transplant
; 22(4): 698-704, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26785332
12.
Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens.
Blood
; 123(10): 1615-20, 2014 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-24435046
13.
Single Daily Busulfan Dosing for Infants with Nonmalignant Diseases Undergoing Reduced-Intensity Conditioning for Allogeneic Hematopoietic Progenitor Cell Transplantation.
Biol Blood Marrow Transplant
; 21(9): 1612-21, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26025482
14.
Secondary malignant neoplasms after high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma.
Pediatr Blood Cancer
; 61(8): 1350-6, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24634399
15.
Scurvy: a new problem for patients with chronic GVHD involving mucous membranes; an easy problem to resolve.
Pediatr Transplant
; 18(5): 524-6, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24816030
16.
Exostoses as a long-term sequela after pediatric hematopoietic progenitor cell transplantation: potential causes and increase risk of secondary malignancies from Ann & Robert H. Lurie Children's Hospital of Chicago.
Biol Blood Marrow Transplant
; 19(8): 1267-70, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23721826
17.
Feasibility of a tandem autologous peripheral blood stem cell transplant regimen for high risk neuroblastoma in a cooperative group setting: a Pediatric Oncology Group study: a report from the Children's Oncology Group.
Pediatr Blood Cancer
; 59(5): 902-7, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22744917
18.
Association Between the Magnitude of Intravenous Busulfan Exposure and Development of Hepatic Veno-Occlusive Disease in Children and Young Adults Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation.
Transplant Cell Ther
; 28(4): 196-202, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35065280
19.
Busulfan dosing in children with BMIs ≥ 85% undergoing HSCT: a new optimal strategy.
Biol Blood Marrow Transplant
; 17(9): 1383-8, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21288495
20.
Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313.
Blood
; 114(7): 1429-36, 2009 Aug 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-19528536